Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Case Report

Published on 04 Apr 2025

Systemic therapy with pemigatinib and sintilimab followed by resection for recurrent FGFR-2-positive intrahepatic cholangiocarcinoma: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuchen Yang
Jingfeng Li
Di Ma
Fengjie Hao
Weixia Li
Jing Xie
Lihan Qian
Junqing Wang
Yongjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1527372

Original Research

Published on 03 Apr 2025

Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lu-Huai Feng
Lu Wei
Bobin Hu
Hengkai Liang
Qingmei Li
Qianbing Yin
Tumei Su
Long Huang
Hongqian Liang
Jianning Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1574317

183 views

Case Report

Published on 03 Apr 2025

Rare case report: primary small-cell neuroendocrine carcinoma of the gallbladder

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Haichen Wang
Qinglin Li
Shaoqi Han
Hu Tian

Frontiers in Oncology

doi 10.3389/fonc.2025.1524974

169 views

Original Research

Accepted on 31 Mar 2025

Identifying novel biomarkers for biliary tract cancer based on volatile organic compounds analysis and machine learning

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jingrong Qian
Qi Liu
Jue Wang
Xuewei Zhuang
Jun Fang

Frontiers in Oncology

doi 10.3389/fonc.2025.1572460

Original Research

Accepted on 31 Mar 2025

HALP Score as a Prognostic Marker for Overall Survival in Advanced Pancreatic Cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Nazan Demir
İvo Gökmen
Yasemin Sağdıç Karateke
Ayşegül İlhan
Fatih Yıldız
Duygu Bayır Garbioğlu
Bülent Yıldız

Frontiers in Oncology

doi 10.3389/fonc.2025.1542463

Original Research

Accepted on 31 Mar 2025

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Li
Jian-Hong Zhong
Xiao-Dong Zhu
Chuangye Han
Jiabei Wang
Hong-Zhi Liu
Kuan Hu
Yang-Xun Pan
Hui-Chuan Sun
Tao Peng

Frontiers in Oncology

doi 10.3389/fonc.2025.1515640

Original Research

Accepted on 31 Mar 2025

Efficacy and Safety of TACE Combined with TKIs and PD-1 inhibitors in HCC Patients with Prior TIPS

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kai Xiong
Kuiyuan Huang
Yulong Liu
Huajin Pang
Peng Chen
Yalu Zheng
Tengzheng Li
Li Zhangyun
Moran Zhang
Dandan Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570029

General Commentary

Published on 31 Mar 2025

Commentary: Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Elettra Merola
Andrea Michielan
Armando Gabbrielli

Frontiers in Oncology

doi 10.3389/fonc.2025.1456557

Review

Published on 28 Mar 2025

Circular RNA in liver cancer research: biogenesis, functions, and roles

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jiayi Wang
Congcong Zhang
Yinghui Zhang
Jiaojiao Guo
Chenyu Xie
Yulu Liu
Lidian Chen
Liangliang Ma

Frontiers in Oncology

doi 10.3389/fonc.2025.1523061

314 views

Systematic Review

Accepted on 27 Mar 2025

Mapping the knowledge domains of literature on hepatocellular carcinoma and liver failure: A bibliometric approach

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jun Pu
Yamin Zhao
Siming Zhang
Tianqi Wu
Ruizi Liu
Tianyi Yuan
Songnian He
Qingyu Hao
Haixia Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1529297

Case Report

Published on 27 Mar 2025

Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Koushiro Ohtsubo
Shigeki Sato
Hiroyuki Sakaguchi
Hiroshi Kotani
Akihiro Nishiyama
Kaname Yamashita
Seiji Yano
Fumihito Toshima
Dai Inoue
Toshifumi Gabata

Frontiers in Oncology

doi 10.3389/fonc.2025.1551038

341 views

Case Report

Published on 27 Mar 2025

Long-term survival was achieved through multidisciplinary treatment of a patient with gallbladder carcinosarcoma accompanied by KRAS mutation: a case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yedan Liao
Junbo Lai
Jilan Yang
Tingfeng Long
Xi Wu
Dan Luo
Jin Tan
Ke Zhang
Jiadai Tang
Lin Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1506949

351 views

Original Research

Accepted on 26 Mar 2025

Comparative Efficacy of Interventional Therapy with or without Targeted Immunotherapy in Child-Pugh B Hepatocellular Carcinoma Patients: a singlecenter, retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xuwei Guo
Man Zhao
Xiao-Ling Duan
Guangjie Han
Wang Jinfeng
Jianfei Shi
Xin Han
Guang Yang
Fei Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1541805

Systematic Review

Published on 26 Mar 2025

Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: a Systematic Review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qingchen Meng
Xiaohang Li
Hongxin Lang

Frontiers in Oncology

doi 10.3389/fonc.2025.1559491

162 views

Original Research

Accepted on 25 Mar 2025

Longitudinal Study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with Percutaneous Ablation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huhu Ren
Jian Chen
Zhiqun Wu
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1566865

Original Research

Published on 25 Mar 2025

Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yiyun Ni
Bin Liu
Weizhen Zhang
Yilin Pang
Yaling Tian
Qingsong Lv
Shengwen Shi
Yang Zheng
Huihui Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1533865

408 views